Document is current

Any future updates will be listed below

Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series

Crossref DOI link: https://doi.org/10.1007/s11239-021-02521-4

Published Online: 2021-07-08

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark